PCLO and hepatocellular carcinoma: In another study, 34 long-term follow-up HCC patients with peripheral blood mononucleoside mutations, such as TP53, CTNNB1, PLCB1, PCLO, ROBO1, BAZ2B, and TTN, and HCC clinical processes were analyzed.